Bahram Badlou | Decision Sciences | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Bahram Badlou
BBAdvies and Research, Netherlands.

Bahram Badlou
Affiliation BBAdvies and Research
Country Netherlands
Scopus ID 6506336018
Documents 14
Citations 250
h-index 7
Subject Area Decision Sciences
Event International Academic Achievements & Awards
ORCID 0000-0001-8391-0269

Bahram Badlou is a researcher affiliated with BBAdvies and Research, whose published work addresses hematology, transfusion science, immunology and metabolic disease. He is recognized with the Innovative Research Award at the International Academic Achievements & Awards for contributions that connect laboratory findings with broader questions of public health [1][2].

Abstract

This article summarizes the research profile of Bahram Badlou in connection with the Innovative Research Award. His publications examine hematologic and immunological changes after COVID-19 [1][3], the potential reversibility of diabetic processes [2], and the effects of nanoparticles on gene expression in human adipocytes [4].

Keywords

Hematology, hemato-immunology, COVID-19, diabetes, platelet preservation, superparamagnetic iron oxide nanoparticles, adipocytes, decision sciences.

Introduction

Research that links blood biology, immune function and metabolic regulation contributes to understanding how chronic and infectious diseases affect the body over time. Bahram Badlou works independently through BBAdvies and Research, and his Scopus record lists 14 documents published over more than a decade [5]. His work includes journal articles, a published response to a review article on platelet preservation, and recent papers on post-pandemic hematologic disorders.

Research Profile

According to Scopus, Badlou’s Author ID is 6506336018, with 14 documents, 250 citations and an h-index of 7. His indexed subject area is Decision Sciences [5]. His main research themes include:

  • Hematologic and immunological effects of COVID-19 variants
  • Mechanisms and possible reversal of diabetic processes
  • Platelet storage and transfusion science
  • Nanoparticle effects on metabolic gene expression

Research Contributions

In 2013, Badlou and colleagues reported that superparamagnetic iron oxide nanoparticles alter the expression of genes associated with obesity and type 2 diabetes in human adipocytes, a finding relevant to the safe biomedical use of nanomaterials [4].

More recently, he published on the possible reversibility of diabetic processes [2]. He has also written on the increase in hematologic disorders observed after COVID-19 [3] and on updates in hematology and immunology intended to reduce excess mortality [1].

Publications

  • Badlou, B. A. (2024). Post COVID-19 war era, hematologic and hemato-immunological updates needed to prevent accelerated death triangle machinery affecting excessive mortality rate. Hematology & Transfusion International Journal. https://doi.org/10.15406/htij.2024.12.00332 [1]
  • Badlou, B. A. (2023). Diabetic processes are potentially reversible. Series of Endocrinology, Diabetes and Metabolism. https://doi.org/10.54178/jsedmv5i2001 [2]
  • Badlou, B. A. (2023). Postcovid-19 war era, hematologic disorders significantly increased by Covid-19 variants, mysteriously. Hematology & Transfusion International Journal. https://doi.org/10.15406/htij.2023.11.00296 [3]

Research Impact

With 250 citations and an h-index of 7, Badlou’s record shows sustained scholarly engagement [5]. The 2013 study on iron oxide nanoparticles and adipocyte gene expression is an example of work that has been cited within the nanomedicine and metabolic research literature [4], while his recent papers contribute to discussion of post-pandemic hematologic health.

Award Suitability

Badlou is considered suitable for the Innovative Research Award for the following reasons:

  • A research record spanning hematology, immunology and metabolism [5]
  • Original proposals on post-COVID-19 hematologic outcomes [3]
  • Interdisciplinary work connecting nanotechnology and disease risk genes [4]
  • Measurable citation impact in the Scopus database

Conclusion

Bahram Badlou’s research combines hematology, immunology and metabolic science, and addresses questions of ongoing public health relevance. His recognition with the Innovative Research Award reflects the originality and breadth of his contributions [1][4].

References

  1. Badlou, B. A. (2024). Post COVID-19 war era, hematologic and hemato-immunological updates needed to prevent accelerated death triangle machinery affecting excessive mortality rate. Hematology & Transfusion International Journal.
    https://doi.org/10.15406/htij.2024.12.00332
  2. Badlou, B. A. (2023). Diabetic processes are potentially reversible. Series of Endocrinology, Diabetes and Metabolism.
    https://doi.org/10.54178/jsedmv5i2001
  3. Badlou, B. A. (2023). Postcovid-19 war era, hematologic disorders significantly increased by Covid-19 variants, mysteriously. Hematology & Transfusion International Journal.
    https://doi.org/10.15406/htij.2023.11.00296
  4. Badlou, B. (2013). Superparamagnetic iron oxide nanoparticles alter expression of obesity and T2D-associated risk genes in human adipocytes. Scientific Reports.
    https://doi.org/10.1038/srep02173
  5. Elsevier. (n.d.). Scopus author details: Bahram Badlou, Author ID 6506336018. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6506336018